CoChat
Sign Up
Cited by 1,582Peripheral Artery Disease ManagementVascular Procedures and ComplicationsDiabetic Foot Ulcer Assessment and Management

The DOI matches its Crossref record; 687 of the 700 references it cites were found in a registry or an index.

Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia

Open access
Conte, Michael S., Bradbury, Andrew W., Kolh, Philippe, White, John V., Dick, Florian, Fitridge, Robert, Mills, Joseph L., Ricco, Jean-Baptiste, Suresh, Kalkunte R., Murad, M. Hassan, Aboyans, Victor, Aksoy, Murat, Alexandrescu, Vlad-Adrian, Armstrong, David, Azuma, Nobuyoshi, Belch, Jill, Bergoeing, Michel, Bjorck, Martin, Chakfé, Nabil, Cheng, Stephen, Dawson, Joseph, Debus, Eike S., Dueck, Andrew, Duval, Susan, Eckstein, Hans H., Ferraresi, Roberto, Gambhir, Raghvinder, Gargiulo, Mauro, Geraghty, Patrick, Goode, Steve, Gray, Bruce, Guo, Wei, Gupta, Prem C., Hinchliffe, Robert, Jetty, Prasad, Komori, Kimihiro, Lavery, Lawrence, Liang, Wei, Lookstein, Robert, Menard, Matthew, Misra, Sanjay, Miyata, Tetsuro, Moneta, Greg, Munoa Prado, Jose A., Munoz, Alberto, Paolini, Juan E., Patel, Manesh, Pomposelli, Frank, Powell, Richard, Robless, Peter, Rogers, Lee, Schanzer, Andres, Schneider, Peter, Taylor, Spence, De Ceniga, Melina V., Veller, Martin, Vermassen, Frank, Wang, Jinsong, Wang, Shenming·2019·European Journal of Vascular and Endovascular Surgery
DOI 10.1016/j.ejvs.2019.05.006PMC PMC8369495
Open this paper in CoChat — free account

Abstract

Guideline summary Chronic limb-threatening ischemia (CLTI) is associated with mortality, amputation, and impaired quality of life. These Global Vascular Guidelines (GVG) are focused on definition, evaluation, and management of CLTI with the goals of improving evidence-based care and highlighting critical research needs. The term CLTI is preferred over critical limb ischemia, as the latter implies threshold values of impaired perfusion rather than a continuum. CLTI is a clinical syndrome defined by the presence of peripheral artery disease (PAD) in combination with rest pain, gangrene, or a lower limb ulceration >2 weeks duration. Venous, traumatic, embolic, and nonatherosclerotic etiologies are excluded. All patients with suspected CLTI should be referred urgently to a vascular specialist. Accurately staging the severity of limb threat is fundamental, and the Society for Vascular Surgery Threatened Limb Classification system, based on grading of Wounds, Ischemia, and foot Infection (WIfI) is endorsed. Objective hemodynamic testing, including toe pressures as the preferred measure, is required to assess CLTI. Evidence-based revascularization (EBR) hinges on three independent axes: Patient risk, Limb severity, and ANatomic complexity (PLAN). Average-risk and high-risk patients are defined by estimated procedural and 2-year all-cause mortality. The GVG proposes a new Global Anatomic Staging System (GLASS), which involves defining a preferred target artery path (TAP) and then estimating limb-based patency (LBP), resulting in three stages of complexity for intervention. The optimal revascularization strategy is also influenced by the availability of autogenous vein for open bypass surgery. Recommendations for EBR are based on best available data, pending level 1 evidence from ongoing trials. Vein bypass may be preferred for average-risk patients with advanced limb threat and high complexity disease, while those with less complex anatomy, intermediate severity limb threat, or high patient risk may be favored for endovascular intervention. All patients with CLTI should be afforded best medical therapy including the use of antithrombotic, lipid-lowering, antihypertensive, and glycemic control agents, as well as counseling on smoking cessation, diet, exercise, and preventive foot care. Following EBR, long-term limb surveillance is advised. The effectiveness of nonrevascularization therapies (eg, spinal stimulation, pneumatic compression, prostanoids, and hyperbaric oxygen) has not been established. Regenerative medicine approaches (eg, cell, gene therapies) for CLTI should be restricted to rigorously conducted randomizsed clinical trials. The GVG promotes standardization of study designs and end points for clinical trials in CLTI. The importance of multidisciplinary teams and centers of excellence for amputation prevention is stressed as a key health system initiative.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejvs.2019.05.006

Cites

687 of 687 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

13 of the 700 references couldn’t be matched to a known paper.

Research works printed but not linked: 128

  1. Macfarlane, 1999, Classification of diabetic foot ulcers: the S(AD) SAD system, Diabetic Foot, 2, 123
  2. Salaun, 2018, Comparison of ankle pressure, systolic toe pressure, and transcutaneous oxygen pressure to predict major amputation after 1 year in the COPART cohort, Angiology
  3. Peeters, 2008, Will heparin-bonded PTFE replace autologous venous conduits in infrapopliteal bypass?, Ital J Vasc Endovasc Surg, 15, 143
  4. Baumann, 2013, Clinically driven need for secondary interventions after endovascular revascularization of tibial arteries in patients with critical limb ischemia, Vasa, 42, 57
  5. Bosiers, 2015, The PES-BTK-70 study: final results of the assessment of the first self-expanding nitinol paclitaxel eluting stent in below-the-knee lesions, EuroIntervention
  6. Yiu, 2015, The roles of drug-eluting technology and atherectomy in infrapopliteal occlusive disease, Ital J Vasc Endovasc Surg, 22, 1
  7. Bradbury, 2010, Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy, J Vasc Surg, 51, 5S, 10.1016/j.jvs.2010.01.073 · DOI
  8. Pappalardo, 2013, Wound healing simplification: a vertical and horizontal philosophy illustrated, J Wound Technol, 19, 38
  9. Wang, 2016, A systematic review and meta-analysis of tests to predict wound healing in diabetic foot, J Vasc Surg, 63, 29S, 10.1016/j.jvs.2015.10.004 · DOI · Paper page
  10. Beropoulis, 2016, Validation of the Wound, Ischemia, foot Infection (WIfI) classification system in nondiabetic patients treated by endovascular means for critical limb ischemia, J Vasc Surg, 64, 95, 10.1016/j.jvs.2016.01.040 · DOI
  11. Ward, 2017, Outcomes of critical limb ischemia in an urban, safety net hospital population with high WIfI amputation scores, Ann Vasc Surg, 38, 84, 10.1016/j.avsg.2016.08.005 · DOI
  12. Darling, 2016, Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system following infrapopliteal endovascular interventions for critical limb ischemia, J Vasc Surg, 64, 616, 10.1016/j.jvs.2016.03.417 · DOI
  13. Lijmer, 1996, ROC analysis of noninvasive tests for peripheral arterial disease, Ultrasound Med Biol, 22, 391, 10.1016/0301-5629(96)00036-1 · DOI
  14. Aboyans, 2008, The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects, J Vasc Surg, 48, 1197, 10.1016/j.jvs.2008.06.005 · DOI
  15. Salaun, 2018, Comparison of ankle pressure, systolic toe pressure, and transcutaneous oxygen pressure to predict major amputation after 1 year in the COPART cohort, Angiology
  16. Larch, 1997, Value of color duplex sonography for evaluation of tibioperoneal arteries in patients with femoropopliteal obstruction: a prospective comparison with anterograde intraarterial digital subtraction angiography, J Vasc Surg, 25, 629, 10.1016/S0741-5214(97)70288-X · DOI
  17. Adriaensen, 2004, Peripheral arterial disease: therapeutic confidence of CT versus digital subtraction angiography and effects on additional imaging recommendations, Radiology, 233, 385, 10.1148/radiol.2331031595 · DOI
  18. Hingorani, 2004, A comparison of magnetic resonance angiography, contrast arteriography, and duplex arteriography for patients undergoing lower extremity revascularization, Ann Vasc Surg, 18, 294, 10.1007/s10016-004-0039-0 · DOI
  19. Hingorani, 2008, Limitations of and lessons learned from clinical experience of 1,020 duplex arteriography, Vascular, 16, 147, 10.2310/6670.2008.00014 · DOI
  20. Met, 2009, Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis, JAMA, 301, 415, 10.1001/jama.301.4.415 · DOI
  21. 1997, Long-term mortality and its predictors in patients with critical leg ischaemia. The I.C.A.I. Group (Gruppo di Studio dell'Ischemia Cronica Critica degli Arti Inferiori). The Study Group of Criticial Chronic Ischemia of the Lower Exremities, Eur J Vasc Endovasc Surg, 14, 91
  22. Faglia, 2014, Effectiveness of combined therapy with angiotensin-converting enzyme inhibitors and statins in reducing mortality in diabetic patients with critical limb ischemia: an observational study, Diabetes Res Clin Pract, 103, 292, 10.1016/j.diabres.2013.12.060 · DOI
  23. Armstrong, 2014, Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease, J Am Heart Assoc, 3, e000697, 10.1161/JAHA.113.000697 · DOI
  24. 2002, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71 · DOI · Paper page
  25. Baigent, 2009, Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials, Lancet, 373, 1849, 10.1016/S0140-6736(09)60503-1 · DOI · Paper page
  26. 1996, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3 · DOI · Paper page
  27. Hiatt, 2017, Ticagrelor versus clopidogrel in symptomatic peripheral artery disease, N Engl J Med, 376, 32, 10.1056/NEJMoa1611688 · DOI · Paper page
  28. Anand, 2007, Oral anticoagulant and antiplatelet therapy and peripheral arterial disease, N Engl J Med, 357, 217, 10.1056/NEJMoa065959 · DOI · Paper page
  29. Mills, 2011, Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of >40 000 patients, Eur Heart J, 32, 1409, 10.1093/eurheartj/ehr035 · DOI
  30. 2002, MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial, Lancet, 360, 7, 10.1016/S0140-6736(02)09327-3 · DOI · Paper page
  31. Meade, 2002, Bezafibrate in men with lower extremity arterial disease: randomised controlled trial, BMJ, 325, 1139, 10.1136/bmj.325.7373.1139 · DOI · Paper page
  32. Leng, 2000, Lipid-lowering for lower limb atherosclerosis, Cochrane Database Syst Rev, 2, CD000123
  33. Aung, 2007, Lipid-lowering for peripheral arterial disease of the lower limb, Cochrane Database Syst Rev, 4, CD000123
  34. Rodriguez, 2017, Association between intensity of statin therapy and mortality in patients with atherosclerotic cardiovascular disease, JAMA Cardiol, 2, 47, 10.1001/jamacardio.2016.4052 · DOI
  35. Wright, 2015, A randomized trial of intensive versus standard blood-pressure control, N Engl J Med, 373, 2103, 10.1056/NEJMoa1511939 · DOI · Paper page
  36. Bavry, 2010, Outcomes among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy, Hypertension, 55, 48, 10.1161/HYPERTENSIONAHA.109.142240 · DOI · Paper page
  37. Cushman, 2010, Effects of intensive blood-pressure control in type 2 diabetes mellitus, N Engl J Med, 362, 1575, 10.1056/NEJMoa1001286 · DOI · Paper page
  38. Moise, 2016, Comparative cost-effectiveness of conservative or intensive blood pressure treatment guidelines in adults aged 35-74 years: the Cardiovascular Disease Policy Model, Hypertension, 68, 88, 10.1161/HYPERTENSIONAHA.115.06814 · DOI
  39. Nathan, 2005, Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes, N Engl J Med, 353, 2643, 10.1056/NEJMoa052187 · DOI · Paper page
  40. van Dieren, 2014, Intensification of medication and glycaemic control among patients with type 2 diabetes—the ADVANCE trial, Diabetes Obes Metab, 16, 426, 10.1111/dom.12238 · DOI
  41. Selvin, 2004, Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus, Ann Intern Med, 141, 421, 10.7326/0003-4819-141-6-200409210-00007 · DOI · Paper page
  42. Palmer, 2016, Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis, JAMA, 316, 313, 10.1001/jama.2016.9400 · DOI
  43. Nawaz, 1998, Clinical risk associated with contrast angiography in metformin treated patients: a clinical review, Clin Radiol, 53, 342, 10.1016/S0009-9260(98)80005-6 · DOI
  44. Goergen, 2010, Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin, Radiology, 254, 261, 10.1148/radiol.09090690 · DOI
  45. Blomster, 2016, The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial, BMJ Open, 6, e009668, 10.1136/bmjopen-2015-009668 · DOI
  46. Newhall, 2017, Impact and duration of brief surgeon-delivered smoking cessation advice on attitudes regarding nicotine dependence and tobacco harms for patients with peripheral arterial disease, Ann Vasc Surg, 38, 113, 10.1016/j.avsg.2016.06.005 · DOI
  47. Athyros, 2013, The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study, Curr Vasc Pharmacol, 11, 779, 10.2174/1570161111311050016 · DOI · Paper page
  48. Dagenais, 2005, Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial, Eur J Cardiovasc Prev Rehabil, 12, 75, 10.1177/204748730501200112 · DOI
  49. Kondo, 2011, Smoking and smoking cessation in relation to all-cause mortality and cardiovascular events in 25,464 healthy male Japanese workers, Circ J, 75, 2885, 10.1253/circj.CJ-11-0416 · DOI · Paper page
  50. Schanzer, 2008, Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data, J Vasc Surg, 48, 1464, 10.1016/j.jvs.2008.07.062 · DOI
  51. Bradbury, 2010, Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision making, J Vasc Surg, 51, 52S, 10.1016/j.jvs.2010.01.077 · DOI
  52. Meltzer, 2013, The Comprehensive Risk Assessment for Bypass (CRAB) facilitates efficient perioperative risk assessment for patients with critical limb ischemia, J Vasc Surg, 57, 1186, 10.1016/j.jvs.2012.09.083 · DOI
  53. Simons, 2016, A comparative evaluation of risk-adjustment models for benchmarking amputation-free survival after lower extremity bypass, J Vasc Surg, 63, 990, 10.1016/j.jvs.2015.09.051 · DOI
  54. Biancari, 2007, Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: a Finnvasc registry study, World J Surg, 31, 217, 10.1007/s00268-006-0242-y · DOI
  55. Lavery, 2008, Prediction of healing for postoperative diabetic foot wounds based on early wound area progression, Diabetes Care, 31, 26, 10.2337/dc07-1300 · DOI
  56. Sheehan, 2003, Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial, Diabetes Care, 26, 1879, 10.2337/diacare.26.6.1879 · DOI
  57. Snyder, 2010, A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeks, Ostomy Wound Manage, 56, 44
  58. Cardinal, 2008, Early healing rates and wound area measurements are reliable predictors of later complete wound closure, Wound Repair Regen, 16, 19, 10.1111/j.1524-475X.2007.00328.x · DOI
  59. Abu Dabrh, 2015, The natural history of untreated severe or critical limb ischemia, J Vasc Surg, 62, 1642, 10.1016/j.jvs.2015.07.065 · DOI
  60. Cull, 2014, An early validation of the Society for Vascular Surgery lower extremity threatened limb classification system, J Vasc Surg, 60, 1535, 10.1016/j.jvs.2014.08.107 · DOI
  61. Zhan, 2015, The Society for Vascular Surgery lower extremity threatened limb classification system based on Wound, Ischemia, and foot Infection (WIfI) correlates with risk of major amputation and time to wound healing, J Vasc Surg, 61, 939, 10.1016/j.jvs.2014.11.045 · DOI
  62. Causey, 2016, Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program, J Vasc Surg, 63, 1563, 10.1016/j.jvs.2016.01.011 · DOI
  63. Robinson, 2017, Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI) score correlates with the intensity of multimodal limb treatment and patient-centered outcomes in patients with threatened limbs managed in a limb preservation center, J Vasc Surg, 66, 488, 10.1016/j.jvs.2017.01.063 · DOI
  64. Seeger, 1987, Preoperative saphenous and cephalic vein mapping as an adjunct to reconstructive arterial surgery, Ann Surg, 205, 733, 10.1097/00000658-198706000-00016 · DOI
  65. Wengerter, 1990, Influence of vein size (diameter) on infrapopliteal reversed vein graft patency, J Vasc Surg, 11, 525, 10.1016/0741-5214(90)90297-N · DOI
  66. Schanzer, 2007, Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial, J Vasc Surg, 46, 1180, 10.1016/j.jvs.2007.08.033 · DOI
  67. Harward, 1995, Limb-threatening ischemia due to multilevel arterial occlusive disease. Simultaneous or staged inflow/outflow revascularization, Ann Surg, 221, 498, 10.1097/00000658-199505000-00007 · DOI
  68. Zukauskas, 1995, Sequential aortofemoropopliteal/distal bypass for treatment of critical lower-limb ischaemia, Cardiovasc Surg, 3, 671, 10.1016/0967-2109(96)82868-7 · DOI
  69. Jongkind, 2010, A systematic review of endovascular treatment of extensive aortoiliac occlusive disease, J Vasc Surg, 52, 1376, 10.1016/j.jvs.2010.04.080 · DOI
  70. Ye, 2011, Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions, J Vasc Surg, 53, 1728, 10.1016/j.jvs.2011.02.005 · DOI
  71. Deloose, 2017, Primary stenting is nowadays the gold standard treatment for TASC II A & B iliac lesions: the definitive MISAGO 1-year results, J Cardiovasc Surg (Torino), 58, 416
  72. Indes, 2013, Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis, J Endovasc Ther, 20, 443, 10.1583/13-4242.1 · DOI
  73. Chiu, 2010, Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease, Eur J Vasc Endovasc Surg, 39, 460, 10.1016/j.ejvs.2009.12.014 · DOI
  74. Ricco, 2008, Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease, J Vasc Surg, 47, 45, 10.1016/j.jvs.2007.08.050 · DOI
  75. Kang, 2008, Common femoral artery occlusive disease: contemporary results following surgical endarterectomy, J Vasc Surg, 48, 872, 10.1016/j.jvs.2008.05.025 · DOI
  76. Ballotta, 2010, Common femoral artery endarterectomy for occlusive disease: an 8-year single-center prospective study, Surgery, 147, 268, 10.1016/j.surg.2009.08.004 · DOI
  77. Chang, 2008, Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease, J Vasc Surg, 48, 362, 10.1016/j.jvs.2008.03.042 · DOI
  78. Baumann, 2011, Endovascular treatment of common femoral artery obstructions, J Vasc Surg, 53, 1000, 10.1016/j.jvs.2010.10.076 · DOI
  79. Bonvini, 2011, Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures, J Am Coll Cardiol, 58, 792, 10.1016/j.jacc.2011.01.070 · DOI
  80. Gouëffic, 2017, Stenting or surgery for de novo common femoral artery stenosis, JACC Cardiovasc Interv, 10, 1344, 10.1016/j.jcin.2017.03.046 · DOI
  81. Siracuse, 2016, Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative, J Vasc Surg, 63, 958, 10.1016/j.jvs.2015.09.063 · DOI
  82. Chae, 2016, Is angiosome-targeted angioplasty effective for limb salvage and wound healing in diabetic foot? A meta-Analysis, PLoS One, 11, e0159523, 10.1371/journal.pone.0159523 · DOI
  83. Jongsma, 2017, Angiosome-directed revascularization in patients with critical limb ischemia, J Vasc Surg, 65, 1208, 10.1016/j.jvs.2016.10.100 · DOI
  84. Biancari, 2014, Angiosome-targeted lower limb revascularization for ischemic foot wounds: systematic review and meta-analysis, Eur J Vasc Endovasc Surg, 47, 517, 10.1016/j.ejvs.2013.12.010 · DOI
  85. Sumpio, 2013, Clinical implications of the angiosome model in peripheral vascular disease, J Vasc Surg, 58, 814, 10.1016/j.jvs.2013.06.056 · DOI
  86. Azuma, 2012, Factors influencing wound healing of critical ischaemic foot after bypass surgery: is the angiosome important in selecting bypass target artery?, Eur J Vasc Endovasc Surg, 43, 322, 10.1016/j.ejvs.2011.12.001 · DOI
  87. Schillinger, 2006, Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery, N Engl J Med, 354, 1879, 10.1056/NEJMoa051303 · DOI
  88. Saxon, 2008, Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease, J Vasc Interv Radiol, 19, 823, 10.1016/j.jvir.2008.02.008 · DOI
  89. Dake, 2011, Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results, Circ Cardiovasc Interv, 4, 495, 10.1161/CIRCINTERVENTIONS.111.962324 · DOI
  90. Rosenfield, 2015, Trial of a paclitaxel-coated balloon for femoropopliteal artery disease, N Engl J Med, 373, 145, 10.1056/NEJMoa1406235 · DOI
  91. Mills, 1992, Contribution of routine intraoperative completion arteriography to early infrainguinal bypass patency, Am J Surg, 164, 506, 10.1016/S0002-9610(05)81190-0 · DOI
  92. Bandyk, 1994, Intraoperative duplex scanning of arterial reconstructions: fate of repaired and unrepaired defects, J Vasc Surg, 20, 426, 10.1016/0741-5214(94)90142-2 · DOI
  93. Ubbink, 2013, Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia, Cochrane Database Syst Rev, 2, CD004001
  94. Abu Dabrh, 2015, Nonrevascularization-based treatments in patients with severe or critical limb ischemia, J Vasc Surg, 62, 1330, 10.1016/j.jvs.2015.07.069 · DOI
  95. Vietto, 2018, Prostanoids for critical limb ischaemia, Cochrane Database Syst Rev, 1, CD006544
  96. Smith, 2012, Intravenous naftidrofuryl for critical limb ischaemia, Cochrane Database Syst Rev, 7, CD002070
  97. Kranke, 2015, Hyperbaric oxygen therapy for chronic wounds, Cochrane Database Syst Rev, 6, CD004123
  98. Game, 2016, Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review, Diabetes Metab Res Rev, 32, 154, 10.1002/dmrr.2707 · DOI
  99. Santema, 2018, Hyperbaric oxygen therapy in the treatment of ischemic lower-extremity ulcers in patients with diabetes: results of the DAMO2CLES multicenter randomized clinical trial, Diabetes Care, 41, 112, 10.2337/dc17-0654 · DOI · Paper page
  100. Peeters Weem, 2015, Bone marrow derived cell therapy in critical limb ischemia: a meta-analysis of randomized placebo controlled trials, Eur J Vasc Endovasc Surg, 50, 775, 10.1016/j.ejvs.2015.08.018 · DOI
  101. Elsherif, 2018, Quality of time spent without symptoms of disease or toxicity of treatment for transmetatarsal amputation versus digital amputation in diabetic patients with digital gangrene, Vascular, 26, 142, 10.1177/1708538117718108 · DOI
  102. Siracuse, 2015, Impact of "do not resuscitate" status on the outcome of major vascular surgical procedures, Ann Vasc Surg, 29, 1339, 10.1016/j.avsg.2015.05.014 · DOI
  103. Aziz, 2015, The influence of do-not-resuscitate status on the outcomes of patients undergoing emergency vascular operations, J Vasc Surg, 61, 1538, 10.1016/j.jvs.2014.11.087 · DOI
  104. Reed, 2008, Major lower extremity amputation after multiple revascularizations: was it worth it?, Ann Vasc Surg, 22, 335, 10.1016/j.avsg.2007.07.039 · DOI
  105. Rollins, 1985, Isolated profundaplasty for limb salvage, J Vasc Surg, 2, 585, 10.1016/0741-5214(85)90014-X · DOI
  106. Miksic, 1986, Profunda femoris revascularization in limb salvage, J Cardiovasc Surg (Torino), 27, 544
  107. Ayoub, 1993, Thru-knee amputation: the operation of choice for non-ambulatory patients, Am Surg, 59, 619
  108. Taylor, 2008, "Successful outcome" after below-knee amputation: an objective definition and influence of clinical variables, Am Surg, 74, 607, 10.1177/000313480807400707 · DOI
  109. Webster, 2012, Prosthetic fitting, use, and satisfaction following lower-limb amputation: a prospective study, J Rehabil Res Dev, 49, 1493, 10.1682/JRRD.2012.01.0001 · DOI
  110. Glaser, 2013, Fate of the contralateral limb after lower extremity amputation, J Vasc Surg, 58, 1571, 10.1016/j.jvs.2013.06.055 · DOI
  111. Bradley, 2006, Secondary prevention of arteriosclerosis in lower limb vascular amputees: a missed opportunity, Eur J Vasc Endovasc Surg, 32, 491, 10.1016/j.ejvs.2006.07.005 · DOI
  112. Bedenis, 2015, Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery, Cochrane Database Syst Rev, 2, CD000535
  113. Abbruzzese, 2004, Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts, J Vasc Surg, 39, 1178, 10.1016/j.jvs.2003.12.027 · DOI
  114. Henke, 2004, Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality, J Vasc Surg, 39, 357, 10.1016/j.jvs.2003.08.030 · DOI
  115. Suckow, 2015, Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival, J Vasc Surg, 61, 126, 10.1016/j.jvs.2014.05.093 · DOI
  116. Brown, 2008, Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery, Cochrane Database Syst Rev, 4, CD000535
  117. Willigendael, 2005, Smoking and the patency of lower extremity bypass grafts: a meta-analysis, J Vasc Surg, 42, 67, 10.1016/j.jvs.2005.03.024 · DOI
  118. Hobbs, 2003, Smoking cessation strategies in patients with peripheral arterial disease: an evidence-based approach, Eur J Vasc Endovasc Surg, 26, 341, 10.1016/S1078-5884(03)00356-3 · DOI
  119. Belch, 2010, Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial, J Vasc Surg, 52, 825, 10.1016/j.jvs.2010.04.027 · DOI
  120. Gassman, 2014, Aspirin usage is associated with improved prosthetic infrainguinal bypass graft patency, Vascular, 22, 105, 10.1177/1708538112473977 · DOI
  121. Bhatt, 2006, Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events, N Engl J Med, 354, 1706, 10.1056/NEJMoa060989 · DOI
  122. Cassar, 2005, Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after lower limb angioplasty, Br J Surg, 92, 159, 10.1002/bjs.4810 · DOI
  123. Strobl, 2013, Twelve-month results of a randomized trial comparing mono with dual antiplatelet therapy in endovascularly treated patients with peripheral artery disease, J Endovasc Ther, 20, 699, 10.1583/13-4275MR.1 · DOI
  124. Tepe, 2012, Management of peripheral arterial interventions with mono or dual antiplatelet therapy—the MIRROR study: a randomised and double-blinded clinical trial, Eur Radiol, 22, 1998, 10.1007/s00330-012-2441-2 · DOI
  125. Mills, 2001, The natural history of intermediate and critical vein graft stenosis: recommendations for continued surveillance or repair, J Vasc Surg, 33, 273, 10.1067/mva.2001.112701 · DOI
  126. Nguyen, 2004, Infrainguinal vein bypass graft revision: factors affecting long-term outcome, J Vasc Surg, 40, 916, 10.1016/j.jvs.2004.08.038 · DOI
  127. Bui, 2012, The natural history of duplex-detected stenosis after femoropopliteal endovascular therapy suggests questionable clinical utility of routine duplex surveillance, J Vasc Surg, 55, 346, 10.1016/j.jvs.2011.08.010 · DOI
  128. Humphries, 2011, Early duplex scanning after infrainguinal endovascular therapy, J Vasc Surg, 53, 353, 10.1016/j.jvs.2010.08.045 · DOI

Cited by

Sorted by citations

See all 1,582

Related

See all

Metadata

Authors
Conte, M. S., Bradbury, A. W., Kolh, P., White, J. V., Dick, F., Fitridge, R., Mills, J. L., Ricco, J.-B., Suresh, K. R., Murad, M. H., Aboyans, V., Aksoy, M., Alexandrescu, V.-A., Armstrong, D., Azuma, N., Belch, J., Bergoeing, M., Bjorck, M., Chakfé, N., Cheng, S., Dawson, J., Debus, E. S., Dueck, A., Duval, S., Eckstein, H. H., Ferraresi, R., Gambhir, R., Gargiulo, M., Geraghty, P., Goode, S., Gray, B., Guo, W., Gupta, P. C., Hinchliffe, R., Jetty, P., Komori, K., Lavery, L., Liang, W., Lookstein, R., Menard, M., Misra, S., Miyata, T., Moneta, G., Munoa Prado, J. A., Munoz, A., Paolini, J. E., Patel, M., Pomposelli, F., Powell, R., Robless, P., Rogers, L., Schanzer, A., Schneider, P., Taylor, S., De Ceniga, M. V., Veller, M., Vermassen, F., Wang, J., & Wang, S.
Affiliations
  • University of California, San Francisco (US)
  • University of Birmingham (GB)
  • University of Liège (BE)
  • Advocate Lutheran General Hospital (US)
  • University of Bern (CH)
  • The University of Adelaide (AU)
  • Baylor College of Medicine (US)
  • Université de Poitiers (FR)
  • Mayo Clinic (US)
  • University of Southern California (US)
  • Asahikawa Medical University (JP)
  • University of Dundee (GB)
  • Pontificia Universidad Católica de Chile (CL)
  • Hôpitaux Universitaires de Strasbourg (FR)
  • University of Hong Kong (HK)
  • Royal Adelaide Hospital (AU)
  • Universität Hamburg (DE)
  • Sunnybrook Health Science Centre (CA)
  • University of Minnesota (US)
  • Technical University of Munich (DE)
  • King's College Hospital (GB)
  • University of Bologna (IT)
  • Prisma Health (US)
  • Chinese PLA General Hospital (CN)
  • CARE Hospitals (IN)
  • University of Bristol (GB)
  • University of Ottawa (CA)
  • Nagoya University (JP)
  • The University of Texas Southwestern Medical Center (US)
  • Shanghai Jiao Tong University (CN)
  • Icahn School of Medicine at Mount Sinai (US)
  • Brigham and Women's Hospital (US)
  • Sanno Medical Center (JP)
  • Oregon Health & Science University (US)
  • Universidad de Buenos Aires (AR)
  • Duke University Health System (US)
  • St. Elizabeth's Medical Center (US)
  • Mount Elizabeth Hospital (SG)
  • Kaiser Foundation Hospital (US)
  • University of the Witwatersrand (ZA)
  • Ghent University Hospital (BE)
  • The First Affiliated Hospital, Sun Yat-sen University (CN)
Corresponding author
Conte, Michael S.
ORCID
Venue
European Journal of Vascular and Endovascular Surgery
Publisher
Elsevier BV
Published
2019-07
Volume
58
Issue
1
Pages
S1-S109.e33
ISSN
1078-5884 (ISSN-L)
DOI
10.1016/j.ejvs.2019.05.006
PMC
PMC8369495
OpenAlex
W4239553742
Cited by
1,582
References
700
Citations by year
2026: 266 · 2025: 226 · 2024: 274 · 2023: 214 · 2022: 231 · 2021: 195 · 2020: 144 · 2019: 32
FWCI
143.64
Type
journal article
Language
en
Update notices
erratum (2020-03-01)
Open access
Licence
Locations
  • European Journal of Vascular and Endovascular Surgery (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (publishedVersion, cc-by-nc-nd)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
  • Discovery Research Portal (University of Dundee) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • Open Repository and Bibliography (University of Liège) (submittedVersion)
Funders
  • Cook Medical
  • National Institutes of Health (UL1TR001855)
  • Japan Society for the Promotion of Science (17H04290)
  • National Heart, Lung, and Blood Institute (R01HL098967)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124789)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Surgery › Peripheral Artery Disease Management
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Vascular Procedures and Complications
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
Keywords
critical limb ischemia, peripheral arterial disease, revascularization, WIfI classification, toe pressure, risk stratification, vein bypass, endovascular intervention, optimal medical therapy, regenerative medicine, amputation prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review